ABBOTT INDIA LTD
Business: Abbott Healthcare Solutions
MOLECULE: Olmesartan medoxomil and Hydrochlorothiazide
STRENGTH: Olmesartan medoxomil 20 mg + Hydrochlorothiazide 12.5 mg
BUSINESS AREAS: PHARMACEUTICALS
THERAPY AREAS: CARDIO-DIABETO
STRENGTH: Olmesartan medoxomil 40 mg + Hydrochlorothiazide 12.5 mg
MOLECULE: Olmesartan Medoxomil and Amlodipine
STRENGTH: Olmesartan medoxomil 20 mg + Amlodipine 5 mg
STRENGTH: Olmesartan medoxomil 40 mg + Amlodipine 5 mg
MOLECULE: Metoprolol Succinate and Olmesartan Medoxomil
STRENGTH: Metoprolol Succinate USP equivalent to Metoprolol Tartrate (ER) 25 mg + Olmesartan Medoxomil 20 mg
STRENGTH: Metoprolol Succinate USP equivalent to Metoprolol Tartrate (ER) 50 mg + Olmesartan Medoxomil 20 mg
MOLECULE: Olmesartan Medoxomil, Amlodipine Besilate and Hydrochlorothiazide IP
STRENGTH: Olmesartan Medoxomil 20 mg + Amlodipine Besilate IP 5 mg + Hydrochlorothiazide IP 12.5 mg
MOLECULE: Olmesartan medoxomil
STRENGTH: 20 mg, 40 mg
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.